Evaluation of Therapeutic Segments Including Monoclonal Antibodies, Insulin, Fusion Proteins, Interferons and Gene Therapies; Prediction of Leading National Markets (US, Japan, EU5 and BRIC); Investigation of Top Products Including Humira, Remicade, Lantus and Enbrel; and Assessment of R&D Including Sirukumab and NurOwn
Report Details • Do you need definitive Biologics market data? • Succinct Biologics market analysis? • Technological insight? • Actionable business recommendations?
Read on to discover how this definitive report can transform your own research and save you time. Biologics form a vital part of the treatment portfolio for many serious chronic disorders, including cancer, diabetes, hepatitis and autoimmune diseases such as rheumatoid arthritis. This highly lucrative market is set to experience revenue growth to 2027, but will have to adapt to many new challenges along the way. Those challenges include patent expiries on many leading biological drugs, the emergence of biosimilars and cost-restricting measures in the face of limited national healthcare budgets.
Report highlights • 155 quantitative tables, charts, and graphs across 300 pages • Analysis of key Biologics in the Market • Lantus • NovoLog/NovoRapid • Humalog • Avonex • Rebif • Humira • Remicade • Tysabri • Herceptin • Kadcyla • Perjeta • Enbrel • Eylea • OsteoCel Plus • Trinity Evolution and Trinity Elite • Apligraf • Dermagraft • IMLYGIC
Global Biologics market outlook and analysis from to 2027
Global Biologics submarket forecasts and analysis from to 2027 • Protein therapeutics, with sub-forecasting for insulin, other recombinant hormones, plasma and recombinant coagulating factors, interferons, enzyme replacement and other agents • Monoclonal antibodies (mAbs) • Fusion proteins • Regenerative medicine, with sub-forecasting for stem cell treatment, tissue engineering and gene therapy • Vaccines
Regional Biologics market forecasts to 2027 • US forecast to 2027 • EU5 forecast to 2027 • Germany forecast to 2027 • UK forecast to 2027 • France forecast to 2027 • Italy forecast to 2027 • Spain forecast to 2027 • Japan forecast to 2027 • BRIC forecast to 2027 • Brazil forecast to 2027 • Russia forecast to 2027 • India forecast to 2027 • China forecast to 2027
Key questions answered • What does the future hold for the Pharmaceutical industry with regards to Biologics? • Where should you target your business strategy? • Which applications should you focus upon? • Which disruptive technologies should you invest in? • Which companies should you form strategic alliances with? • Which company is likely to success and why? • What business models should you adopt? • What industry trends should you be aware of?
KEY FINDINGS The global market for viral vector vaccines is expected to grow at a CAGR of 18.19% over the forecast period of 2019-2027. Promising results from several clinical studies performed by various organizations have emphasized the potential of viral-vector-based vaccines and therapies for gene therapies. MARKET...
The global drug of abuse testing market is projected to cross US$ 5 Billion by 2024. Drugs of abuse testing involves detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. The use of illicit drugs is increasing across the globe. According to the United Nations Office on Drugs and Crime, nearly...
111 pages •
By Infiniti Research Limited
• Oct 2018
About Sjogren’s Syndrome Sjogren’s syndrome is an autoimmune disorder and the major symptoms of this disorder are dry eyes and dry mouth. The mucous membranes produce reduced tears, and moisture-secreting glands in the mouth secrete smaller amounts of saliva. Technavio’s analysts forecast the Global Sjogren’s Syndrome...
110 pages •
By Infiniti Research Limited
• Oct 2018
About Diffuse Large B-Cell Lymphoma DLBCL is a cancer of B-lymphocytes. It is the most common type of NHL among adults. It is an aggressive (fast-growing), complex, and difficult-to-treat form of NHL, which refers to a group of cancers of the lymphatic system. Technavio’s analysts forecast the Global DLBCL Therapeutics...
Report Synopsis Personalized medicine has a huge potential in leading the healthcare industry with drastic changes with a key focus on diseases understanding & management integrated with advanced analytics, patient data, customized medicines and other possibilities. Personalized Medicine will transform the entire pharmaceutical...
The report presents a detailed analysis of the Aeromonads diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Aeromonads definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: